BP
HZNP

Ballentine Partners’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

Ballentine Partners’s Portfolio HZNP Stock Details HZNP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-2,987
Closed -$340K – 596
2022
Q4 		$340K Buy
+2,987
New +$340K 0.01% 353
2017
Q4 		– Sell
-10,057
Closed -$128K – 436
2017
Q3 		$128K Sell
10,057
-200
-2% -$2.55K 0.01% 370
2017
Q2 		$139K Buy
+10,257
New +$139K 0.01% 364